Redeye updates on Stillfront following the company's Q4-report which saw stronger EBITDA than expected while revenue was softer than expected. The company also issues new financial targets with focus on organic growth and cash flow generation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/